Xagenic Raises CAD$15M in Funding

Xagenic_logoXagenic, a Toronto, Canada-based molecular diagnostics company developing the lab-free Xagenic X1™ platform for use at the point of care, raised CAD$15M in funding.

Backers included Domain Associates, CTI Life Sciences, BDC Capital and the Ontario Capital Growth Corporation.

The company intends to use the funds to accelerate its development efforts.

Led by Timothy I. Still, Chief Executive Officer, Xagenic provides the Xagenic X1™ platform, which will allow users to perform lab-quality molecular diagnostic tests in the physician office with a time-to-result of 20 minutes.
The company also has a San Francisco office.



Join the discussion